Cas:1243101-05-4 2-(4-oxothieno[3,2-c]pyridin-5-yl)acetic acid manufacturer & supplier

Chemical Name:2-(4-oxothieno[3,2-c]pyridin-5-yl)acetic acid

CAS.NO:1243101-05-4

Synonyms:2-(4-Oxothieno[3,2-c]pyridin-5(4H)-yl)acetic acid

Molecular Formula:C₉H₇NO₃S

Molecular Weight:209.22200

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:87.54000

Exact Mass:209.01500

LogP:1.14760

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(4-Oxothieno[3,2-c]pyridin-5(4H)-yl)acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-Oxothieno[3,2-c]pyridin-5(4H)-yl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-Oxothieno[3,2-c]pyridin-5(4H)-yl)acetic acid Use and application,2-(4-Oxothieno[3,2-c]pyridin-5(4H)-yl)acetic acid technical grade,usp/ep/jp grade.

Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 2-(4-oxothieno[3,2-c]pyridin-5-yl)acetic acid manufacturer Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 2-(4-oxothieno[3,2-c]pyridin-5-yl)acetic acid supplier Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. 2-(4-oxothieno[3,2-c]pyridin-5-yl)acetic acid vendor In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China. 2-(4-oxothieno[3,2-c]pyridin-5-yl)acetic acid factory Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs).